These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20026137)

  • 1. Agonist-induced restoration of hippocampal neurogenesis and cognitive improvement in a model of cholinergic denervation.
    Van Kampen JM; Eckman CB
    Neuropharmacology; 2010 May; 58(6):921-9. PubMed ID: 20026137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Selective M
    Lebois EP; Trimper JB; Hu C; Levey AI; Manns JR
    ACS Chem Neurosci; 2016 Oct; 7(10):1393-1405. PubMed ID: 27479319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraseptal muscarinic ligands and galanin: influence on hippocampal acetylcholine and cognition.
    Elvander E; Schött PA; Sandin J; Bjelke B; Kehr J; Yoshitake T; Ogren SO
    Neuroscience; 2004; 126(3):541-57. PubMed ID: 15183504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counteractive effects of a partial (sabcomeline) and a full (RS86) muscarinic receptor agonist on deficits in radial maze performance induced by S-AMPA lesions of the basal forebrain and medial septal area.
    Hodges H; Peters S; Gray JA; Hunter AJ
    Behav Brain Res; 1999 Feb; 99(1):81-92. PubMed ID: 10512575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions.
    McDonald MP; Willard LB; Wenk GL; Crawley JN
    J Neurosci; 1998 Jul; 18(13):5078-85. PubMed ID: 9634573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation.
    Lin L; Georgievska B; Mattsson A; Isacson O
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12108-13. PubMed ID: 10518584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic tone sustains impulse flow in the septohippocampal GABA but not cholinergic pathway: implications for learning and memory.
    Alreja M; Wu M; Liu W; Atkins JB; Leranth C; Shanabrough M
    J Neurosci; 2000 Nov; 20(21):8103-10. PubMed ID: 11050132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 192IGG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus.
    Rossner S; Schliebs R; Härtig W; Bigl V
    Brain Res Bull; 1995; 38(4):371-81. PubMed ID: 8535860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focused ultrasound-induced blood-brain barrier opening improves adult hippocampal neurogenesis and cognitive function in a cholinergic degeneration dementia rat model.
    Shin J; Kong C; Lee J; Choi BY; Sim J; Koh CS; Park M; Na YC; Suh SW; Chang WS; Chang JW
    Alzheimers Res Ther; 2019 Dec; 11(1):110. PubMed ID: 31881998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models.
    Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS
    Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesion of septal-hippocampal neurons with 192 IgG-saporin alters function of M1 muscarinic receptors.
    Potter PE; Gaughan C; Assouline Y
    Neuropharmacology; 1999 Apr; 38(4):579-86. PubMed ID: 10221761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice.
    Seo H; Ferree AW; Isacson O
    Eur J Neurosci; 2002 Feb; 15(3):498-506. PubMed ID: 11876777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease.
    Zhang H; Petit GH; Gaughwin PM; Hansen C; Ranganathan S; Zuo X; Smith R; Roybon L; Brundin P; Mobley WC; Li JY
    J Huntingtons Dis; 2013; 2(1):69-82. PubMed ID: 25063430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin restores loss of hippocampal neurogenesis and cholinergic innervation and reduces innate immune expression and reversal learning deficits in adult male and female rats following adolescent ethanol exposure.
    Macht V; Vetreno R; Elchert N; Fisher R; Crews F
    Alcohol Clin Exp Res (Hoboken); 2023 Mar; 47(3):470-485. PubMed ID: 36799290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
    Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
    Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of cerebral function by CS-932, a functionally selective M1 partial agonist: neurochemical characterization and pharmacological studies.
    Iwata N; Kozuka M; Hara T; Kanek T; Tonohiro T; Sugimoto M; Niitsu Y; Kondo Y; Yamamoto T; Sakai J; Nagano M
    Jpn J Pharmacol; 2000 Nov; 84(3):266-80. PubMed ID: 11138727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease.
    Fisher A; Brandeis R; Bar-Ner RH; Kliger-Spatz M; Natan N; Sonego H; Marcovitch I; Pittel Z
    J Mol Neurosci; 2002; 19(1-2):145-53. PubMed ID: 12212772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late treatment with choline alfoscerate (l-alpha glycerylphosphorylcholine, α-GPC) increases hippocampal neurogenesis and provides protection against seizure-induced neuronal death and cognitive impairment.
    Lee SH; Choi BY; Kim JH; Kho AR; Sohn M; Song HK; Choi HC; Suh SW
    Brain Res; 2017 Jan; 1654(Pt A):66-76. PubMed ID: 27765578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice.
    Fisher A; Brandeis R; Chapman S; Pittel Z; Michaelson DM
    J Neurochem; 1998 May; 70(5):1991-7. PubMed ID: 9572284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.